Il-Mi Okazaki
6PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Feb 11, 2022
PD-1 agonism by anti-CD80 inhibits T cell activation and alleviates autoimmunity.Daisuke Sugiura, Il-Mi Okazaki, Takeo K Maeda
|Aug 26, 2021
PD-1 preferentially inhibits the activation of low-affinity T cells.Kenji Shimizu, Daisuke Sugiura, Il-Mi Okazaki
|Sep 15, 2020
LAG-3: from molecular functions to clinical applications.Takumi Maruhashi, Daisuke Sugiura, Il-Mi Okazaki
|Nov 15, 2019
Glucocorticoids potentiate the inhibitory capacity of programmed cell death 1 by up-regulating its expression on T cells.Natsumi Maeda, Takumi Maruhashi, Daisuke Sugiura
|Apr 20, 2019
Restriction of PD-1 function by cis-PD-L1/CD80 interactions is required for optimal T cell responses.Daisuke Sugiura, Takumi Maruhashi, Il-Mi Okazaki
|Oct 24, 2018
LAG-3 inhibits the activation of CD4+ T cells that recognize stable pMHCII through its conformation-dependent recognition of pMHCII.Takumi Maruhashi, Il-Mi Okazaki, Daisuke Sugiura
Pageof 1
